Novartis India hits 52-week low on poor Q1 results

Image
Capital Market
Last Updated : Jul 25 2013 | 10:20 AM IST

Novartis India lost 4.5% to Rs 450 at 09:45 IST on BSE after net profit declined 48.6% to Rs 13.87 crore on 1.7% rise in net sales to Rs 219.03 crore in Q1 June 2013 over Q1 June 2012.

The company announced Q1 result after market hours on Wednesday, 24 July 2013.

Meanwhile, the BSE Sensex was down 9.60 points, or 0.05%, to 20,081.08.

On BSE, 6,235 shares were traded in the counter as against an average daily volume of 19,890 shares in the past one quarter.

The stock hit 52-week low of Rs 448 in intraday trade today, 25 July 2013. The stock hit a high of Rs 460 so far during the day. The stock had hit a 52-week high of Rs 740.40 on 11 September 2012.

The stock had underperformed the market over the past one month till 24 July 2013, rising 0.12% compared with the Sensex's 8.36% gain. The scrip had also underperformed the market in past one quarter, sliding 19.45% as against Sensex's rise of 4.75%.

The small-cap company has an equity capital of Rs 15.98 crore. Face value per share is Rs 5.

Novartis India said that core business, pharmaceuticals recorded total income from operations of Rs 162.8 crore in Q1 June 2013 from Rs 162 crore in Q1 June 2012. The generics business registered total income from operations of Rs 15 crore in Q1 June 2013 from Rs 15.7 crore in Q1 June 2012. The animal health business registered total income from operations of Rs 25.6 crore in Q1 June 2013 from Rs 21.9 crore in Q1 June 2012. The OTC business recorded total income from operations of Rs 19.9 crore in Q1 June 2013 from Rs 19.9 crore in Q1 June 2012.

Novartis India said financial results for Q1 June 2013 were adversely impacted by significant rupee depreciation and slowdown in sales due to reduction in trade stocks after notification of the new drug price control order in May 2013. The expanded scope of drug price control is likely to have a significant impact on both revenue and profitability of the company. Necessary steps are being taken to reduce the adverse impact, the company said.

Powered by Capital Market - Live News

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 25 2013 | 10:03 AM IST

Next Story